• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Venture

Siena Venture targets €25m close before year-end
Siena Venture targets €25m close before year-end

Debut fund from the new VC player held a first close on 1 February

  • Funds
  • 02 February 2021
Lauxera Growth I holds €100m first close
Lauxera Growth I holds €100m first close

Fund is dedicated to financing and accelerating the commercial growth of promising healthtech companies

  • Funds
  • 27 January 2021
Sinergia Venture Fund holds €30m first close
Sinergia Venture Fund holds €30m first close

Fund invests in pre-series-A and series-A rounds to support the growth of startups operating across a large variety of sectors

  • Funds
  • 25 January 2021
Octopus to launch £100m healthcare-focused fund
Octopus to launch £100m healthcare-focused fund

In conjunction with the announcement, the firm has hired an investment team from TenX Health

  • Funds
  • 25 January 2021
Blue Horizon Ventures closes debut fund on €183m
Blue Horizon Ventures closes debut fund on €183m

Food-technology-focused VC was founded in 2018 and has so far made 18 investments

  • Venture
  • 20 January 2021
New Baltic fund targets €30m to back female founders
New Baltic fund targets €30m to back female founders

Fund targets Baltic and Nordic startups with female founders and gender-balanced executive teams

  • Funds
  • 20 January 2021
Heal Capital closes debut fund on €100m
Heal Capital closes debut fund on €100m

Healthtech-focused VC sees opportunities in the developing European market, managing director Christian Weiß tells Unquote

  • Venture
  • 18 January 2021
LSP launches €150m fund dedicated to dementia treatment
LSP launches €150m fund dedicated to dementia treatment

Vehicle invests in companies that are developing drugs for neurodegenerative diseases

  • Funds
  • 13 January 2021
BGV closes fourth fund on €140m
BGV closes fourth fund on €140m

Following this fundraise, the firm expects to expand the investment team with one or two hires

  • Funds
  • 07 January 2021
Iberia Fundraising Pipeline - Q4 2020
Iberia Fundraising Pipeline - Q4 2020

Unquote compiles a roundup of the most notable fundraises ongoing across the Iberian market

  • Funds
  • 14 December 2020
Wellington Hadley Harbor III closes on $1.8bn
Wellington Hadley Harbor III closes on $1.8bn

In addition to the capital raised, the fund also has access to up to $400m from co-investors

  • Funds
  • 09 December 2020
Forbion V closes on €460m hard-cap
Forbion V closes on €460m hard-cap

Investors in Forbion V include a mix of existing and new LPs including Pantheon and Argentum

  • Funds
  • 08 December 2020
Sova VC makes first investment from debut fund
Sova VC makes first investment from debut fund

Although sector agnostic, the Sova VC team has a focus on technology and healthcare

  • Funds
  • 08 December 2020
Highland Europe closes fourth fund on €700m hard-cap
Highland Europe closes fourth fund on €700m hard-cap

Kirkland & Ellis provided legal advice and the firm did not use a placement agent

  • Funds
  • 07 December 2020
Scale Venture Partners Fund VII closes on $600m
Scale Venture Partners Fund VII closes on $600m

Fund targets software startups, with a special focus on cloud infrastructure, cybersecurity and AI

  • Funds
  • 07 December 2020
Target Global holds first close for second growth fund on €300m
Target Global holds first close for second growth fund on €300m

Target Global I closed on €300m in 2015 and is now fully deployed

  • Funds
  • 02 December 2020
Andreessen Horowitz raises $4.5bn across two funds
Andreessen Horowitz raises $4.5bn across two funds

VC raises $1.3bn for its seventh early-stage fund and $3.2bn for its second growth fund

  • Funds
  • 25 November 2020
GSK spinout SR One closes $500m debut fund
GSK spinout SR One closes $500m debut fund

Biotechnology-focused vehicle will invest in Europe and the US, with GSK as cornerstone investor

  • Venture
  • 20 November 2020
Astanor Ventures I closes on $325m
Astanor Ventures I closes on $325m

One family office from Asia has invested in the fund, but the majority are based in Europe and the US

  • Funds
  • 20 November 2020
C5 to hold double close in December 2020
C5 to hold double close in December 2020

Launched in February 2020, the firm's impact fund has made two investments, including Enveil

  • Funds
  • 19 November 2020
Novalis Biotech aims for January second close for new €25m fund
Novalis Biotech aims for January second close for new €25m fund

Belgian VC Novalis held a first close on €8m for its second fund on 8 November

  • Funds
  • 19 November 2020
Nordic Fundraising Pipeline - Q4 2020
Nordic Fundraising Pipeline - Q4 2020

Unquote compiles a round up of the most notable fundraises ongoing across the Nordic market

  • Funds
  • 17 November 2020
Faber launches €30m second tech fund
Faber launches €30m second tech fund

Fund is dedicated to early-stage rounds, with a focus on data science, artificial intelligence and machine learning

  • Funds
  • 16 November 2020
Speedinvest holds first close for Speedinvest x Fund 2
Speedinvest holds first close for Speedinvest x Fund 2

VC also announced the appointment of Tier Mobilty co-founder Julian Blessin as partner

  • Venture
  • 12 November 2020
121314
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013